Conference Abstract
 
Navigation
Conference Abstracts Index

Abstracts - 2006 London

Abstracts - 2005 Zurich

Abstracts - 2004 Berlin

Abstracts - 2003 Barcelona

Abstracts - 2002 Brussels

Abstracts - 2001 Tokyo

Abstracts - 2000 Marburg

       

O#15   Minoxidil - how does it work?

Andrew Messenger. Dept of Dermatology, Royal Hallamshire Hospital, Sheffield S10 2JF, UK

The hypertrichotic effect of minoxidil was recognised soon after it became available for treating hypertension in the early 1970s. However, despite the passage of 30 years and major advances in hair biology we still have little understanding of its mode of action on hair growth.
Initial suggestions that minoxidil stimulates hair growth by increasing scalp blood flow have not been substantiated although this remains a possibility. The relaxant property of minoxidil on vascular smooth muscle is due to the action of its metabolite, minoxidil sulphate, as a cell surface potassium channel opener (PCO). Some other PCOs stimulate hair growth in animal studies and the sulfotransferase enzymes responsible for minoxidil sulphation are expressed in the hair follicle. However, attempts to prove that minoxidil stimulates hair growth by opening potassium channels have met with little success. In cultured cells of skin or hair follicle origin minoxidil has been reported to have a variety of other effects. These include increased cell proliferation or delayed senescence, stimulation of prostaglandin synthesis, stimulation of VEGF and inhibition of lysyl hydroxylase. Some of these studies used concentrations of minoxidil unlikely to be achieved in vivo and their relevance to hair growth is uncertain. Organ culture studies have been disappointing. Some studies have reported the minoxidil increases DNA synthesis in vibrissae follicle cultures but no clear effect has been observed in human follicles. The response of human hair growth to topical minoxidil is very rapid - an increase in hair follicle numbers occurs within a few weeks - suggesting that minoxidil acts on the hair cycle to initiate anagen in latent follicles. This phase of the hair cycle has not been modelled in vitro, perhaps explaining the lack of response in organ culture experiments. The pharmacology of minoxidil action on hair growth has not attracted the attention it deserves. A better understanding may help to explain aspects of normal hair biology as well as leading to more effective treatments for hair loss